Central nervous system pharmacology of neuropeptide Y

Pharmacol Ther. 1995 Mar;65(3):397-414. doi: 10.1016/0163-7258(95)98598-k.


Neuropeptide Y (NPY) is a 36-amino acid peptide belonging to the pancreatic polypeptide family that has marked and diverse biological activity across species. NPY originally was isolated from mammalian brain tissue somewhat more than 10 years ago and, since that time, has been the subject of numerous scientific publications. NPY and its proposed three receptors (Y1, Y2 and Y3) are relatively abundant in and uniquely distributed throughout the brain and spinal cord. This review will highlight the results from a number of research-oriented studies that have examined how NPY is involved in CNS function and behavior, and how these studies may relate to the possible development of medicines, either NPY-like agonists or antagonists, directed towards the treatment of disorders such as anxiety, pain, hypertension, schizophrenia, memory dysfunction, abnormal eating behavior and depression.

Publication types

  • Review

MeSH terms

  • Animals
  • Central Nervous System / drug effects*
  • Humans
  • Mental Disorders / drug therapy
  • Neuropeptide Y / pharmacology*


  • Neuropeptide Y